School of Medicine
Showing 701-750 of 1,233 Results
-
Brittany Elizabeth Matheson, PhD
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioBrittany Matheson, PhD, is a clinical associate professor and licensed clinical psychologist in the Eating Disorders Clinic. She completed her undergraduate degree at Duke University, doctorate from the Joint Doctoral Program in Clinical Psychology at San Diego State University and the University of California, San Diego, and APA clinical internship at Lucile Packard Children’s Hospital Stanford (LPCH)/Children’s Health Council. Dr. Matheson is a certified family-based treatment (FBT) therapist and consultant. She is also the director of the Stanford Eating Disorder Research Program Data Coordination Center and collaborates with colleagues on NIH-funded randomized clinical trials. Dr. Matheson's research interests include examining the psychosocial, neurocognitive, and familial factors related to disordered eating and excess weight gain in youth. She is interested in the development and implementation of evidence-based treatments for youth with disordered eating as well as better understanding factors that influence pediatric bariatric surgery outcomes. Dr. Matheson has specialized research and clinical expertise in the interplay among obesity, disordered eating, and autism spectrum disorder and is the director of psychological services for the LPCH adolescent metabolic and bariatric surgery program. She conducts comprehensive evaluations and provides evidence-based treatments for individuals across the age-spectrum with eating disorders, including anorexia nervosa, bulimia nervosa, binge eating disorder, avoidant/restrictive food intake disorder, and other specified feeding and eating disorders. Her recent research focuses on reducing access to care barriers by digitizing evidence-based treatments and utilizing technology to enhance treatment outcomes.
-
Ryan Matlow
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioRyan Matlow, Ph.D., is a child clinical psychologist who serves as Director of Community Programs for Stanford’s Early Life Stress and Resilience Program, and is a faculty member in Stanford's Human Rights and Trauma Mental Health Program. His clinical and research efforts focus on understanding and addressing the impact of stress, adversity, and trauma in children, families, and communities. In particular, Dr. Matlow seeks to apply current scientific knowledge of the neurobiological and developmental impact of stress, trauma, and adversity in shaping interventions and systems of care. Dr. Matlow is focused on engaging diverse populations and providing evidence-based individual, family, and systems interventions for posttraumatic stress following interpersonal trauma, with an emphasis on efforts in school, community, and integrated care settings. He is engaged in clinical service, program development, and interdisciplinary collaboration efforts that address childhood trauma exposure in communities that have been historically marginalized, under-resourced, and/or experienced human rights violations. He has worked extensively in providing trauma-focused psychological evaluation, treatment, and advocacy services with immigrant youth and families, with a focus on immigrants from Latin American countries. Dr. Matlow is involved in the training and dissemination of Stanford's Cue Centered Therapy (Carrion, 2015), a flexible, manualized intervention addressing childhood experiences of chronic trauma.
-
Mohamad Matout, MD, MSc
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Mohamad Matout is a board-certified, fellowship-trained psychiatrist with Stanford Health Care. He is also a clinical assistant professor in the Department of Psychiatry and Behavioral Sciences at Stanford University School of Medicine.
Dr. Matout specializes in using brain stimulation therapies to treat mental illnesses and neurological disorders that do not respond to standard treatments. These therapies include deep brain stimulation (DBS), electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). He serves as the attending psychiatrist for the Youth TMS Clinic at Stanford Health Care, providing transcranial magnetic stimulation for adolescents with treatment-resistant mood disorders. Dr. Matout also uses avatar therapy, an investigational treatment for psychosis that involves using a digital avatar to represent the voices a patient hears.
Dr. Matout’s research centers on brain health as a unifying framework for understanding psychiatric illness across the lifespan. Using a statistical modeling technique called psychometric network analysis, he maps how psychiatric symptoms mutually reinforce or suppress one another. This method reveals the structure of mental illness beyond traditional diagnostic categories. Dr. Matout developed the approach through his graduate work on brain health in HIV and post-COVID syndrome. He now applies it to neuromodulation (changing nerve signals for treatment) and other novel interventions.
Dr. Matout’s two primary lines of research are TMS for adolescents and avatar therapy. He also contributes to a broader range of neuromodulation studies through collaboration with the Brain Stimulation Lab at Stanford University School of Medicine. Beyond his clinical and research work, Dr. Matout is co-founder of AVAtalk Technologies Inc., a mental health technology startup focused on avatar-based therapeutic solutions.
Dr. Matout has authored peer-reviewed publications in Social Psychiatry and Psychiatric Epidemiology, Quality of Life Research, and CEN Case Reports. He has also contributed chapters to Current Medical Diagnosis & Treatment 2027 and Katzung & Trevor's Basic & Clinical Pharmacology (17th ed., McGraw-Hill, in press).
Dr. Matout is a member of the American Neuropsychiatric Association (ANPA) and the Brain Stimulation Society (BraSS), where he serves as assistant treasurer. -
LAWRENCE McGLYNN
Clinical Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Current Research and Scholarly InterestsMethamphetamine Abuse
HIV Neuropsychiatry -
Mark McGovern
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences) and, by courtesy, of Pediatrics
BioDr. Mark McGovern is a Professor and the Associate Chair of Translation and Implementation Research in the Department of Psychiatry & Behavioral Sciences and, by courtesy, the Department of Medicine at Stanford University School of Medicine.
Most people who need health care do not receive it. And of those who do, wide variation exists in access to care and the quality of the care they receive in health care systems, both private and public. Dr. McGovern is a leader in using rigorous methods of implementation science to close these gaps in health care delivery.
His mission is to get the best health care possible to the people who need it the most.
Dr. McGovern's primary focus is the implementation and sustainment of evidence-based interventions and guideline adherent care in public and private health care systems and organizations. Within the hub of the Stanford Center for Dissemination and Implementation (CDI) which he directs, Dr. McGovern is the Principal Investigator (PI) and leads three national implementation research and practice centers: The Center for Dissemination and Implementation At Stanford (C-DIAS); The Research Adoption Support Center (RASC); and, the Mental Health Technology Transfer Center Network Coordinating Center (MHTTC). The 3 centers are federally-funded, respectively by the National Institute on Drug Abuse (P50DA05402), the National Institutes of Health Healing Addiction Long Term (HEAL) initiative (U2CDA057717), and the US Department of Health and Human Services Substance Use and Mental Health Services Administration (H79SM081726). Dr. McGovern is also the PI on a multi-site adaptive implementation trial across a state system of care, which aims to integrate addiction medications for persons with opioid use disorder who are receiving services in specialty or primary care organizations (R01DA052975). In addition, he addresses implementation challenges in federally-qualified health centers (FQHCs) across the State of California, in the Stanford Division of Primary Care and Population Health, and in specialty addiction and mental health treatment organizations nationwide. He leads, facilitates and/or actively engages networks advancing implementation science in health, including the NIDA Clinical Trials Network Translation & Implementation Special Interest Group, the NIDA Clinical Trials Western States Node Translation & Implementation Workgroup, the Stanford University Network for Dissemination & Implementation Research (SUNDIR), the VA Palo Alto HSR&D Center for Innovation to Implementation, and the Stanford Medicine Center for Improvement. He is on the Core Faculty of the National Institute of Mental Health Implementation Research Institute at the Washington University in St. Louis. Dr. McGovern is a collaborator on multiple projects as a co-investigator, consultant, or advisory board member. He is a mentor to numerous individuals across the country and at Stanford, from university undergraduates to mid-career faculty and clinical administrators at academic institutions and health care systems nationwide. -
Carmen McLean
Clinical Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
BioCarmen McLean, PhD, is a clinical psychologist and researcher with the Dissemination and Training Division of the National Center for PTSD at the Palo Alto VA Health Care System. Dr. McLean’s research focuses on increasing the implementation and reach of evidence-based treatments for posttraumatic stress disorder (PTSD).
-
M Windy McNerney, PhD
Clinical Associate Professor (Affiliated), Psych/General Psychiatry and Psychology (Adult)
Staff, Psychiatry and Behavioral SciencesBioDr. M. Windy McNerney is the Director of Biological Sciences for the MIRECC at the Department of Veterans Affairs in Palo Alto, and a Clinical Associate Professor (Affiliated) at Psychiatry and Behavioral Sciences at Stanford School of Medicine. Dr. McNerney holds a particular passion for not only understanding the neurophysiology and biochemistry of mental health diseases, but also advocating for these invisible diseases. Her research focuses on neurodegeneration, depression, TBI, PTSD, and addiction. She is collaborating with researchers to integrate brain imaging and biochemical markers in hopes to better understand these diseases. She also is taking a lead role at the VA in investigating the biochemistry of magnetic brain stimulation and is the leader of the NeuroNado Laboratory. At Stanford University, she is the professor of two popular courses examining the biological and societal issues surrounding substance use disorder, with a major focus on opioids such as fentanyl. She has individually mentored over 25 students from underrepresented groups in STEM activities and leads monthly seminars aimed at facilitating career development. In her free time, she is a community advocate for the treatment of mental health and educates groups about the dangers of fentanyl.
She earned her BS from UC Davis and her PhD from the University of Notre Dame. While at ND, she interned at NASA Ames on Human Factors Engineering. She then went on to a postdoctoral position at Lawrence Livermore National Laboratory (DOE), and then completed a fellowship at the WRIISC program at the VA and Stanford University.
Selected Publications:
McNerney MW, Gurkoff G, Berryhill M (2023). The rehabilitation potential of neurostimulation for mild traumatic brain injury in animal and human studies. Brain Sciences, 13, 1402.
McNerney MW, Kraybill EP Narayanan S, Mojabi F, Venkataramanan V, Heath A (2023). Memory-related hippocampal brain-derived neurotrophic factor activation pathways from repetitive transcranial magnetic stimulation in the 3xTg-AD mouse line. Experimental Gerontology, 183, 11323.
Shuken, S, McNerney MW (2023). Cost and benefits for popular p-value correction methods I three models of quantitative omic experiments. Analytical Chemistry, 95, 2732.
McNerney MW, Heath A, Narayanan S, Yesavage J (2022). Repetitive transcranial magnetic stimulation improves brain-derived neurotrophic factor and cholinergic signaling in the 3xTgAD mouse model of Alzheimer’s disease. Journal of Alzheimer’s Disease, 86, 499..
Heath AM, Brewer M, Yesavage J, McNerney MW. (2021). Improved object recognition memory using post-encoding repetitive transcranial magnetic stimulation. Brain Stimulation, 15, 78.
Yang AC, Vest RT, Kern F, Lee DP, Agam M, Maat CA, Losada PM, Chen MB, Schaum N, Khoury N, Toland A, Calcuttawala K, Shin H, Palovics R, Shin A, Wang EY, Luo J, Gate D, Schultz-Schaeffer WJ, Chu P, Siegenthalar J, McNerney MW, Keller A, Wyss-Coray T (2022). A human brain vascular atlas reveals diverse mediators or Alzheimer’s disease. Nature, 603, 885.
McNerney MW, Hobday T, Cole B, Ganong R, Winas N, Matthews D, Hood J, Lane S (2019). Objective classification of mTBI using machine learning on a combination of frontal electroencephalography measurements and self-reported symptoms. Sports Medicine Open, 4, 14.
McNerney MW, Sheng T, Nechvatal JM, Lee A, Lyons D, Adamson M (2018). Integration of neural and epigenetic contributions to posttraumatic stress symptoms: The role of hippocampal volume and glucocorticoid receptor gene methylation. PLOSONE, e0192222.
Bennion BJ, Be NA, McNerney MW, Lao V, Carlson E, Valdez CA (2017). Predicting a drug’s membrane permeability: A computational model validated with in vitro permeability assay data. Journal of Physical Chemistry, B, 121, 5228.
See more publications at: https://www.ncbi.nlm.nih.gov/pubmed/?term=McNerney%20MW%5BAuthor%5D&cauthor=true&cauthor_uid=17107728 -
Vinod Menon
Rachael L. and Walter F. Nichols, MD, Professor and Professor, by courtesy, of Education and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsEXPERIMENTAL, CLINICAL AND THEORETICAL SYSTEMS NEUROSCIENCE
Cognitive neuroscience; Systems neuroscience; Cognitive development; Psychiatric neuroscience; Functional brain imaging; Dynamical basis of brain function; Nonlinear dynamics of neural systems. -
Mitchell Miglis, MD
Clinical Professor, Adult Neurology
Clinical Professor, Psychiatry and Behavioral Sciences - Sleep MedicineCurrent Research and Scholarly InterestsProdromal markers of neurodegeneration in REM sleep behavior disorder
Autonomic dysfunction in Long-COVID
Postural tachycardia syndrome -
Emmanuel Mignot, MD, PhD
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology and Neurological Sciences
Current Research and Scholarly InterestsThe research focus of the laboratory is the study of sleep and sleep disorders such as narcolepsy and Kleine Levin syndrome. We also study the neurobiological and genetic basis of the EEG and develop new tools to study sleep using nocturnal polysomnography. Approaches mostly involve human genetic studies (GWAS, sequencing), EEG signal analysis (deep learning), and immunology (narcolepsy is an autoimmune disease of the brain). We also work on autoimmune encephalitis.
-
Colleen Mills-Finnerty
Clinical Assistant Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioDr. Mills-Finnerty received her PhD in Psychology from Rutgers University, with a focus on cognitive neuroscience. She completed a MIRECC Advanced Fellowship at the Palo Alto VA and Stanford Dept. Psychiatry and Behavioral Sciences, studying mood disorders using neuroimaging and neurostimulation. She was then awarded a VA Career Development Award to study attention and reward function in mood disorders. She joined the Women’s Operational Military Exposures Network as a Research Scientist in 2024. She is interested in health disparities that impact neurological and mental health in women Veterans, and their relationship to Military Environmental Exposures.
She has authored multiple award-winning papers, including “Affective Neuroscience: Applications for Sexual Medicine Research and Clinical Practice,” proposing a novel treatment schema for sexual trauma based on affective neuroscience, which was awarded the Bronze Prize for Best Paper by the International Society for Sexual Medicine. -
Christina Maria Miranda
Resident in Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioI am a Medical Degree candidate at Stanford University. I am originally from Milford, New Jersey. In 2021, I graduated with a bachelors degree in Neuroscience from the University of Pennsylvania. I am interested in pursuing a career in eating disorder treatment and research. I am also the co-founder and CEO of a Philadelphia-based 501(c)(3) nonprofit organization called Body Empowerment Project. We deliver educational workshops related to body image and self-esteem to Philadelphia public school students using a near-peer mentorship model and a validated body-positive curriculum.
-
Percy Khushroo Mistry
Social Science Research Scholar, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordResearch Scholar, Stanford Cognitive and Systems Neuroscience Laboratory
-
Amrita Mitchell-Krishnan, PhD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Amrita Krishnan received her PhD in Counseling Psychology at New York University. She completed her residency training at Denver Health and fellowship training at CHOC children’s with an emphasis on pediatric psychology.
Dr. Krishnan provides clinical services within the Medical Coping and Wellness Clinic in Child Psychiatry. Additionally, she is an attending psychologist with the pediatric liver transplant team. -
Anish Mitra
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioAnish Mitra is a neuroscientist and psychiatrist interested in understanding how neural activity in large-scale networks causes mental illness.
-
Hylton Molzof, PhD, MPH
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Sleep Medicine
BioDr. Molzof is a Clinical Assistant Professor and Licensed Psychologist in the Department of Psychiatry and Behavioral Sciences, Stanford School of Medicine. She specializes in the assessment and treatment of sleep disorders via behavioral sleep medicine interventions, including Cognitive Behavioral Therapy for Insomnia (CBT-I) and positive airway pressure (PAP) desensitization. She also utilizes evidence-based techniques to help patients better manage circadian rhythm disorders, such as delayed sleep-wake phase disorder and shift work sleep disorder. Inspired by her background in public health, she has a strong interest in quality improvement and program development projects aimed at enhancing the quality and accessibility of sleep and circadian medicine for the diverse patient population served by Stanford Sleep Medicine Center.
-
Michelle Monje
Milan Gambhir Professor of Pediatric Neuro-Oncology and Professor, by courtesy, of Neurosurgery, of Pediatrics, of Pathology and of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsThe Monje Lab studies the molecular and cellular mechanisms of postnatal neurodevelopment. This includes microenvironmental influences on neural precursor cell fate choice in normal neurodevelopment and in disease states.
-
Rudolf Moos
Professor of Psychiatry and Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsOur research group works primarily on psychiatric program evaluation and the quality of health care. The studies focus heavily on health care programs and the context, process, outcome, and cost of care.
-
Kelli Moran-Miller, PhD
Clinical Professor, Psychiatry and Behavioral Sciences
BioDr. Kelli Moran-Miller joined Stanford in Psychiatry & Behavioral Sciences in 2015. She is a licensed psychologist specializing in athlete mental health and sport and performance psychology. She also is a Certified Mental Performance Consultant with the Association of Applied Sport Psychology and a member of the US Olympic Committee registry. In her current role with Stanford Athletics (DAPER), she provides clinical and performance psychology services for varsity student-athletes, coaches, staff, and varsity sport teams. Prior to Stanford, she was the Director of Counseling and Sport Psychology - Athletics at the University of Iowa.
-
Philippe Mourrain
Associate Professor of Psychiatry and Behavioral Sciences (Major Laboratories and Clinical Translational Neurosciences Incubator)
On Partial Leave from 2026-09-01 To 2027-02-28BioExpertise: Neurobiology, Sleep sciences, Molecular Genetics, Developmental Biology, Gene Silencing/Epigenetics
Methodology: Synapse Imaging (Two photon microscopy, Array Tomography), Calcium Imaging (Light Sheet Microscopy/SPIM, Light Field Microscopy), Optogenetics, CLARITY, Tol2 transgenesis, TALENs, CRISPR/Cas9, Video tracking and behavior computation.
